Zhitong Finance App News, Hanyu Pharmaceutical (300199.SZ) issued an announcement. The company recently completed a comparative study on pre-clinical pharmacodynamics of HY3003 tablets for weight loss. Research results showed that HY3003 tablets had a good weight loss effect on DIO mice and DIO rat obesity models. The weight loss effect was superior to that of the already marketed simeglutide tablets under the same experimental conditions, showing good development prospects for this variety.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.